Revenue up 10.7% but PBT swung to a NZ$0.1m loss as costs outpaced growth

PBT swung from a NZ$0.3m profit to a NZ$0.1m loss, and NPAT followed to a NZ$0.2m loss — meaning cost growth absorbed the entire revenue gain and then some. EBITDAF of NZ$1.6m was disclosed as down 11% year-on-year, so the deterioration between EBITDAF and PBT reflects meaningful depreciation and interest charges sitting below that line.

Cash on hand fell to NZ$0.4m from NZ$2.2m in the prior comparable, while gross borrowings edged higher to NZ$30.4m, taking implied net debt to approximately NZ$30.1m. Total liabilities grew 14.4% against a 10.7% revenue increase, suggesting the balance sheet is expanding faster than the business is earning.

The 10.7% revenue increase was not enough to prevent PBT turning negative. The gap between EBITDAF (NZ$1.6m) and PBT (–NZ$0.1m) of roughly NZ$1.7m in a single half-year reflects the weight of depreciation on an aged-care asset base built through recent acquisitions, plus rising interest costs on NZ$30.4m of gross borrowings. Without a material uplift in revenue or improvement in operating cost efficiency, the depreciation and financing burden will continue to suppress statutory earnings.

Leverage is the dominant balance-sheet risk. Net debt of approximately NZ$30.1m against annualised EBITDAF implies a leverage multiple that is high for a business of this revenue scale. The NZ$0.4m cash balance provides limited buffer, and with liabilities growing 14.4%, the balance sheet trajectory warrants scrutiny. This matters because it constrains financial flexibility at a point when the business is still in a building phase.

Operating cash flow is credible but disconnected from statutory earnings. OCF of NZ$2.1m was 129.6% of EBITDAF, which is a sound conversion ratio, and operating cash flow improved modestly from NZ$1.9m in HY23. The divergence between positive OCF and negative NPAT reflects non-cash charges (depreciation, amortisation) rather than underlying cash deterioration — but it does not make the statutory loss immaterial, because those non-cash charges represent real asset consumption and real funding costs.

NPAT in HY23 was also first-half weighted at 55%, implying the prior year's second half earned only NZ$0.3m — a low bar for improvement, but still a profit.

No formal guidance has been provided for FY24. The event overlays note acquisitions in both the prior comparable and full-year anchor periods, so direct year-on-year comparisons carry some basis noise. The release references a strategy review and reset of objectives, and early completion of the Ranfurly Manor Village development, but does not translate these into specific financial targets. Whether the second half can return the full-year result to profitability depends entirely on whether the revenue trajectory accelerates or costs moderate — neither of which is quantified in this release.

However, the earnings quality is weak: EBITDAF itself fell 11% year-on-year despite higher revenue, which means underlying operating margins compressed at the EBITDAF level before depreciation and interest are even considered.

OCF of NZ$2.1m is real cash and reflects the aged-care model's capacity to generate operating receipts from resident care and occupancy fees. The concern is not cash conversion per se — 129.6% OCF-to-EBITDAF is adequate — but rather that the financing structure required to own the underlying assets consumes almost all the operating surplus on a statutory basis. Capital expenditure at NZ$0.2m (1.4% of revenue) is very low in HY24, a sharp reversal from the NZ$13.6m capex in HY23 that reflected the acquisition phase. Maintenance capex at that level appears minimal and raises the question of whether asset investment is being deferred.

This briefing cannot assess the split between care revenue, occupancy fees, and resale/new-sale proceeds within the NZ$12.9m revenue total, which would be necessary to judge the sustainability and mix quality of the top-line growth.